Authors:
Lalej-Bennis, D
Boillot, J
Bardin, C
Zirinis, P
Coste, A
Escudier, E
Chast, F
Peynegre, R
Slama, G
Selam, JL
Citation: D. Lalej-bennis et al., Six month administration of gelified intranasal insulin in 16 type 1 diabetic patients under multiple injections: Efficacy vs subcutaneous injectionsand local tolerance, DIABETE MET, 27(3), 2001, pp. 372-377
Authors:
Lalej-Bennis, D
Boillot, J
Bardin, C
Zirinis, P
Coste, A
Escudier, E
Chast, F
Peynegre, R
Selam, JL
Slama, G
Citation: D. Lalej-bennis et al., Efficacy and tolerance of intranasal insulin administered during 4 months in severely hyperglycaemic Type 2 diabetic patients with oral drug failure:a cross-over study, DIABET MED, 18(8), 2001, pp. 614-618
Authors:
Debrix, I
Tilleul, P
Milleron, B
Grene, N
Bouleuc, C
Roux, D
Liote, H
Madelaine, I
Bellanger, A
Conort, O
Fontan, JE
Le Mercier, F
Bardin, C
Becker, A
Citation: I. Debrix et al., The relationship between introduction of American Society of Clinical Oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris university hospital, CLIN THER, 23(7), 2001, pp. 1116-1127
Authors:
Piketty, C
Bardin, C
Gilquin, J
Gairard, A
Kazatchkine, MD
Chast, F
Citation: C. Piketty et al., Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis, CL MICRO IN, 6(3), 2000, pp. 117-120
Authors:
Grene, N
Pointereau-Bellanger, A
Conort, O
Fontan, JE
Le Mercier, F
Madelaine, I
Bardin, C
Roux, D
Debrix, I
Tilleul, P
Citation: N. Grene et al., Multicenter study of the impact of prescription guidelines on the use of colony stimulating factors, ANTI-CANC D, 11(2), 2000, pp. 109-115
Authors:
Duperrier, K
Eljaafari, A
Dezutter-Dambuyant, C
Bardin, C
Jacquet, C
Yoneda, K
Schmitt, D
Gebuhrer, L
Rigal, D
Citation: K. Duperrier et al., Distinct subsets of dendritic cells resembling dermal DCs can be generatedin vitro from monocytes, in the presence of different serum supplements, J IMMUNOL M, 238(1-2), 2000, pp. 119-131
Authors:
Debrix, I
Madelaine, I
Grenet, N
Roux, D
Bardin, C
Le Mercier, F
Fontan, JE
Connor, O
Pointereau, A
Tilleul, P
Citation: I. Debrix et al., Impact of ASCO guidelines for the use of hematopoietic colony stimulating factors (CSFs): survey results of fifteen Paris university hospitals, PHARM WORLD, 21(6), 1999, pp. 270-271